Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Watching for submission date

$Nyxoah SA (NYXH.US)$ Nyxoah Says DREAM US Pivotal Study Meets Primary Endpoints
Moomoo 24/7· 11 mins ago
Olivier Taelman, Nyxoah's Chief Executive Officer, said, "We are finalizing the fourth and final module submission in the PMA application and I look forward to launching Genio in the U.S, pending FDA approval."
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2268 Views
Comment
Sign in to post a comment
    2823Followers
    29Following
    39KVisitors
    Follow